Resmed (RSMDF) Tax Provisions (2009 - 2026)

Resmed (RSMDF) has reported Tax Provisions for 18 consecutive years, with $90.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Tax Provisions rose 15.81% year-over-year to $90.7 million; the trailing twelve-month figure through Jun 2026 stood at $396.1 million (up 43.09% YoY), and the FY2026 full-year result was $396.1 million, up 43.09% from the prior year.
• Tax Provisions fell to $90.7 million in Q2 2026 per RSMDF's latest filing, from $103.6 million in the prior quarter.
• Across five years, Tax Provisions topped out at $103.6 million in Q1 2026 and bottomed at $43.0 million in Q2 2022.
• Historically, Tax Provisions has averaged $67.3 million across 5 years, with a median of $61.2 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Tax Provisions slumped 84.04% in 2022, then surged 96.73% in 2026.
• Over 5 years, Tax Provisions stood at $48.8 million in 2022, then rose by 3.85% to $50.7 million in 2023, then surged by 45.5% to $73.7 million in 2024, then jumped by 40.51% to $103.6 million in 2025, then decreased by 12.38% to $90.7 million in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $90.7 million, $103.6 million, and $103.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.